Open access · CC-BY
via OpenAlex
Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis
Félix Ignacio Téllez-Ávila, J.F. Sánchez-Ávila, Mauricio García-Saenz-de-Sicilia, Norberto Carlos Chávez-Tapia, Ada M. Franco-Guzmán, Gustavo López-Arce, Eduardo Cerda-Contreras, Misael Uribe
World Journal of Gastroenterology · 2008 · ▲ 68 citations
Abstract
AIM: To evaluate the prevalence of metabolic syndrome (MS), obesity and type 2 diabetes mellitus (T2DM) in a group of Mexican Mestizo patients with cryptogenic cirrhosis (CC) and to compare this group with patients with cirrhosis secondary to other causes (disease controls). METHODS: Patients with CC, diagnosed between January, 1990 and April, 2005, were included in a retrospective study. Patients with cirrhosis caused by chronic hepatitis C, alcohol abuse or autoimmune hepatitis (AIH) served as disease controls. RESULTS: A total of 134 patients with CC were analyzed. Disease controls consisted of 81 patients with chronic hepatitis C, 33 with alcohol abuse and 20 with AIH. The median age of patients with CC was 57 years (range, 16-87); 83 (61.9%) patients were female; 53 (39.6%) were Child A, 65 (48.5%) Child B, and 16 (11.9%) were Child C cirrhosis. The prevalence of MS (29.1% vs 6%; P<0.001), obesity (16.4% vs 8.2%; P=0.04) and T2DM (40% vs 22.4%; P=0.013) was higher in CC patients than in disease controls. There were no differences in sex, age or liver function tests between the two groups. CONCLUSION: The prevalence of MS, obesity and T2DM were higher in patients with CC than in patients with cirrhosis secondary to others causes. Our findings support the hypothesis that non-alcoholic steatohepatitis (NASH) plays an under-recognized role in CC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3748/wjg.14.4771
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Téllez-Ávila, F.I., Sánchez-Ávila, J., García-Saenz-de-Sicilia, M., Chávez-Tapia, N.C., Franco-Guzmán, A.M., López-Arce, G., Cerda-Contreras, E., & Uribe, M. (2008). Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. <em>World Journal of Gastroenterology</em>. https://doi.org/10.3748/wjg.14.4771
Vancouver
Téllez-Ávila FI, Sánchez-Ávila J, García-Saenz-de-Sicilia M, Chávez-Tapia NC, Franco-Guzmán AM, López-Arce G, et al. Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. World Journal of Gastroenterology. 2008. doi:10.3748/wjg.14.4771.
BibTeX
@article{flix2008Preval,
title = {Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis},
author = {Félix Ignacio Téllez-Ávila and J.F. Sánchez-Ávila and Mauricio García-Saenz-de-Sicilia and Norberto Carlos Chávez-Tapia and Ada M. Franco-Guzmán and Gustavo López-Arce and Eduardo Cerda-Contreras and Misael Uribe},
journal = {World Journal of Gastroenterology},
year = {2008},
doi = {10.3748/wjg.14.4771},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Hungarian Institute of Cardiology 2016
Open access · US-GOV
Comparing Body Composition Measurements - Bioelectrical Impedance Analysis and Dual-energy X-ray Absorptiometry - in Chronic Heart Failure
International Journal of Advances in Medicine 2016
Open access · OA
The study of prevalence of hyperuricemia and metabolic syndrome in type 2 diabetes mellitus
Wiadomości Lekarskie 2023
Open access · OA
EFFECT OF INTERMITTENT FASTING ON CARBOHYDRATE, LIPID AND ULTRASONOGRAPHIC PARAMETERS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND PREDIABETES
AIDS 2020
Preprint · CC-BY
Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV
BMC Geriatrics 2015
Open access · CC-BY
Combined association of chronic disease and low skeletal muscle mass with physical performance in older adults in the Sarcopenia and Translational Aging Research in Taiwan (START) study
Asia Pacific journal of clinical nutrition 2026
Citation only